Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.

Pushko P, Sun X, Tretyakova I, Hidajat R, Pulit-Penaloza JA, Belser JA, Maines TR, Tumpey TM.

Vaccine. 2016 Oct 17;34(44):5235-5242. doi: 10.1016/j.vaccine.2016.09.012. Epub 2016 Sep 20.

PMID:
27663671
2.

Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype.

Mallajosyula VV, Citron M, Ferrara F, Temperton NJ, Liang X, Flynn JA, Varadarajan R.

Front Immunol. 2015 Jun 26;6:329. doi: 10.3389/fimmu.2015.00329. eCollection 2015 Jun 26.

3.

Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.

An Y, Rininger JA, Jarvis DL, Jing X, Ye Z, Aumiller JJ, Eichelberger M, Cipollo JF.

J Proteome Res. 2013 Aug 2;12(8):3707-20. doi: 10.1021/pr400329k. Epub 2013 Jul 24.

4.

Evaluation of the Virus CounterĀ® for rapid baculovirus quantitation.

Ferris MM, Stepp PC, Ranno KA, Mahmoud W, Ibbitson E, Jarvis J, Cox MM, Christensen K, Votaw H, Edwards DP, Rowlen KL.

J Virol Methods. 2011 Jan;171(1):111-6. doi: 10.1016/j.jviromet.2010.10.010. Epub 2010 Oct 21.

5.

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13701-6. doi: 10.1073/pnas.1007465107. Epub 2010 Jul 6.

6.

Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, Borisevich V, Linde JJ, Zacks MA, Li H, Kavita U, Reiserova L, Liu X, Dumuren K, Balasubramanian B, Weaver B, Parent J, Umlauf S, Liu G, Huleatt J, Tussey L, Paessler S.

Vaccine. 2009 Sep 25;27(42):5875-84. doi: 10.1016/j.vaccine.2009.07.060. Epub 2009 Aug 3.

7.

Production of a novel influenza vaccine using insect cells: protection against drifted strains.

Cox MM, Karl Anderson D.

Influenza Other Respir Viruses. 2007 Jan;1(1):35-40. doi: 10.1111/j.1750-2659.2006.00007.x. Review.

8.

Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A/H5N1.

Kendirgi F, Yun NE, Linde NS, Zacks MA, Smith JN, Smith JK, McMicken H, Chen Y, Paessler S.

Hum Vaccin. 2008 Nov-Dec;4(6):410-9. Epub 2008 Nov 21.

9.

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

Yun NE, Linde NS, Zacks MA, Barr IG, Hurt AC, Smith JN, Dziuba N, Holbrook MR, Zhang L, Kilpatrick JM, Arnold CS, Paessler S.

Virology. 2008 Apr 25;374(1):198-209. doi: 10.1016/j.virol.2007.12.029. Epub 2008 Jan 29.

Supplemental Content

Support Center